Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
Clinical trial NCT01817192 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01817192
- Sponsor
- Razor Genomics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2027-05-15
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.